CHEMOTHERAPY OF PENILE CARCINOMA

Czech version

Authors: prim. MUDr. Michaela Matoušková
Authors‘ workplace: Urocentrum Praha
Published in: Urol List 2005; 3(4): 18-20

Overview

Penil carcinoma belongs with its low incidence of less than 0,5% of all male oncological diseases to rare tumours. Phimosis and insufficient hygiene are important risk factors. On the contrary the circumcision in the childhood has proved a protection effect. We prove spinocellular carcinoma in more than 95% of patients. Stage I and II are usually curable by both surgical ablation or organ preserving methods (brachytherapy, laserablation etc). Patients´ survival is dependent on nodal affection (N+). Patients without clinically positive nodal affection with infiltrating tumours (> T2), high tumour grading and proved vascular invasion benefit from lymphadenectomy. Lymphadenectomy of palpable nodes usually followed after at least 4-6 weeks of antibiotic therapy. The role of chemotherapy both adjuvant and nonadjuvant, eventually primary in generalized diseases, is nowadays evaluated in prospective clinical studies.

KEY WORDS:
penile carcinoma, chemotherapy, spinocellular carcinoma, circumcision

Sources

1. Berrino F, Capocaccia R, Coleman MP et al.: Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 2003; 14 (Suppl5): 150-153.

2. Wieland U, Jurk S, Weissenborn T et al. Erythroplasia of Queyrat: Coinfection with cutaneous cancerogenic human papillomavirus type 8 and genital papillomaviruses in carcinoma in situ. J Invest Dermatol 2000; 115: 396-401.

3. Burgers JK, Badalament RA, Drago JR. Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin N Am 1992; 19: 247-256.

4. Coral DA, Sella A, Pettaway CA et al. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 1998; 160: 1170-1174.

5. Hass GP, Blumenstein BA, Gagliano RG et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999; 161: 1823-1825.

6. Hussein AM, Benedetto P, Sridhar KS. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 1990; 65: 433-438.

7. Shammas FV, Ous S, Fossa S. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992; 147: 630-632.

8. Fisher HA, Barada JH, Horton J et al. Neoadjuvant therapy with cisplatin and 5-fluorouracil for stage III squamous cell carcinoma of the penis. J Urol 1990; 146: 653.

9. Pizzocaro G, Piva L, Nicolai N. Treatment of lymfatic metastases of squamous cell carcinoma of the penis: experience at the National Tumor Institute of Milan. Arch Ital Urol Androl 1996; 68: 169-172.

10. Joerger M, Warzinek T, Klaeser B et al. Major tumor regression after paclitaxel and carboplatin polychemotherapy in patient with advanced penile cancer. Urology 2004; 63: 778-780.

11. Skeel RT, Huang J, Manola J et al. A phase II study of 13-cis retinoic acid plus interferon aplha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893). Cancer Invest 2003; 21: 41-46.

Labels

Paediatric urologist Urology

LYMPHODRAINAGE OF PENIS

PROBLEMS OF NODAL AFFECTION IN PENILE CARCINOMA

SURGICAL TREATMENT OF PENILE CARCINOMA LOCALIZED IN THE ORGAN

BENIGN DERMATOSIS OF PENIS

PROSTATE CANCER UPDATE

INTERVIEW WITH PROFESSOR PATRIC C. WALSH ABOUT HIS PERSPECTIVE ON RETROPUBIC RADICAL PROSTATECTOMY

BRACHYTHERAPY IN THE TREATMENT OF PENILE CARCINOMA

MALE GENITAL LYMPHEDEMA

Article was published in

Urological Journal

2005 Issue 4